73 related articles for article (PubMed ID: 38673836)
21. Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer.
Osumi H; Shinozaki E; Takeda Y; Wakatsuki T; Ichimura T; Saiura A; Yamaguchi K; Takahashi S; Noda T; Zembutsu H
Cancer Med; 2019 Jan; 8(1):408-417. PubMed ID: 30575318
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies.
Tie J; Cohen JD; Lo SN; Wang Y; Li L; Christie M; Lee M; Wong R; Kosmider S; Skinner I; Wong HL; Lee B; Burge ME; Yip D; Karapetis CS; Price TJ; Tebbutt NC; Haydon AM; Ptak J; Schaeffer MJ; Silliman N; Dobbyn L; Popoli M; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
Int J Cancer; 2021 Feb; 148(4):1014-1026. PubMed ID: 32984952
[TBL] [Abstract][Full Text] [Related]
23. The relevance of tumor mutation profiling in interpretation of NGS data from cell-free DNA in non-small cell lung cancer patients.
Ottestad AL; Wahl SGF; Grønberg BH; Skorpen F; Dai HY
Exp Mol Pathol; 2020 Feb; 112():104347. PubMed ID: 31759951
[TBL] [Abstract][Full Text] [Related]
24. Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer.
Ryoo SB; Heo S; Lim Y; Lee W; Cho SH; Ahn J; Kang JK; Kim SY; Kim HP; Bang D; Kang SB; Yu CS; Oh ST; Park JW; Jeong SY; Kim YJ; Park KJ; Han SW; Kim TY
Br J Cancer; 2023 Aug; 129(2):374-381. PubMed ID: 37280413
[TBL] [Abstract][Full Text] [Related]
25. DREAMS: deep read-level error model for sequencing data applied to low-frequency variant calling and circulating tumor DNA detection.
Christensen MH; Drue SO; Rasmussen MH; Frydendahl A; Lyskjær I; Demuth C; Nors J; Gotschalck KA; Iversen LH; Andersen CL; Pedersen JS
Genome Biol; 2023 Apr; 24(1):99. PubMed ID: 37121998
[TBL] [Abstract][Full Text] [Related]
26. Single duplex DNA sequencing with CODEC detects mutations with high sensitivity.
Bae JH; Liu R; Roberts E; Nguyen E; Tabrizi S; Rhoades J; Blewett T; Xiong K; Gydush G; Shea D; An Z; Patel S; Cheng J; Sridhar S; Liu MH; Lassen E; Skytte AB; Grońska-Pęski M; Shoag JE; Evrony GD; Parsons HA; Mayer EL; Makrigiorgos GM; Golub TR; Adalsteinsson VA
Nat Genet; 2023 May; 55(5):871-879. PubMed ID: 37106072
[TBL] [Abstract][Full Text] [Related]
27. Impact of Whole Genome Doubling on Detection of Circulating Tumor DNA in Colorectal Cancer.
Kabel J; Henriksen TV; Demuth C; Frydendahl A; Rasmussen MH; Nors J; Birkbak NJ; Madsen AH; Løve US; Andersen PV; Kolbro T; Monti A; Thorlacius-Ussing O; Gögenur M; Kildsig J; Schlesinger NH; Bondeven P; Iversen LH; Gotschalck KA; Andersen CL
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831479
[TBL] [Abstract][Full Text] [Related]
28. Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer.
Kotani D; Oki E; Nakamura Y; Yukami H; Mishima S; Bando H; Shirasu H; Yamazaki K; Watanabe J; Kotaka M; Hirata K; Akazawa N; Kataoka K; Sharma S; Aushev VN; Aleshin A; Misumi T; Taniguchi H; Takemasa I; Kato T; Mori M; Yoshino T
Nat Med; 2023 Jan; 29(1):127-134. PubMed ID: 36646802
[TBL] [Abstract][Full Text] [Related]
29. Comparing single-target and multitarget approaches for postoperative circulating tumour DNA detection in stage II-III colorectal cancer patients.
Henriksen TV; Reinert T; Rasmussen MH; Demuth C; Løve US; Madsen AH; Gotschalck KA; Iversen LH; Andersen CL
Mol Oncol; 2022 Oct; 16(20):3654-3665. PubMed ID: 35895438
[TBL] [Abstract][Full Text] [Related]
30. Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.
Tie J; Cohen JD; Lahouel K; Lo SN; Wang Y; Kosmider S; Wong R; Shapiro J; Lee M; Harris S; Khattak A; Burge M; Harris M; Lynam J; Nott L; Day F; Hayes T; McLachlan SA; Lee B; Ptak J; Silliman N; Dobbyn L; Popoli M; Hruban R; Lennon AM; Papadopoulos N; Kinzler KW; Vogelstein B; Tomasetti C; Gibbs P;
N Engl J Med; 2022 Jun; 386(24):2261-2272. PubMed ID: 35657320
[TBL] [Abstract][Full Text] [Related]
31. Effects of Metastatic Sites on Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer.
Bando H; Nakamura Y; Taniguchi H; Shiozawa M; Yasui H; Esaki T; Kagawa Y; Denda T; Satoh T; Yamazaki K; Sunakawa Y; Kato T; Goto M; Yuki S; Nishina T; Oki E; Shinozaki E; Matsuhashi N; Takahashi N; Tsuji A; Ohtsubo K; Wakabayashi M; Ikeno T; Hata M; Odegaard JI; Yoshino T
JCO Precis Oncol; 2022 Apr; 6():e2100535. PubMed ID: 35544728
[TBL] [Abstract][Full Text] [Related]
32. A clinician's handbook for using ctDNA throughout the patient journey.
Hasenleithner SO; Speicher MR
Mol Cancer; 2022 Mar; 21(1):81. PubMed ID: 35307037
[TBL] [Abstract][Full Text] [Related]
33. Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer.
Gale D; Heider K; Ruiz-Valdepenas A; Hackinger S; Perry M; Marsico G; Rundell V; Wulff J; Sharma G; Knock H; Castedo J; Cooper W; Zhao H; Smith CG; Garg S; Anand S; Howarth K; Gilligan D; Harden SV; Rassl DM; Rintoul RC; Rosenfeld N
Ann Oncol; 2022 May; 33(5):500-510. PubMed ID: 35306155
[TBL] [Abstract][Full Text] [Related]
34. Error Characterization and Statistical Modeling Improves Circulating Tumor DNA Detection by Droplet Digital PCR.
Henriksen TV; Drue SO; Frydendahl A; Demuth C; Rasmussen MH; Reinert T; Pedersen JS; Andersen CL
Clin Chem; 2022 May; 68(5):657-667. PubMed ID: 35030248
[TBL] [Abstract][Full Text] [Related]
35. Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences.
Henriksen TV; Tarazona N; Frydendahl A; Reinert T; Gimeno-Valiente F; Carbonell-Asins JA; Sharma S; Renner D; Hafez D; Roda D; Huerta M; Roselló S; Madsen AH; Løve US; Andersen PV; Thorlacius-Ussing O; Iversen LH; Gotschalck KA; Sethi H; Aleshin A; Cervantes A; Andersen CL
Clin Cancer Res; 2022 Feb; 28(3):507-517. PubMed ID: 34625408
[TBL] [Abstract][Full Text] [Related]
36. Clinical correlates of circulating cell-free DNA tumor fraction.
Bredno J; Lipson J; Venn O; Aravanis AM; Jamshidi A
PLoS One; 2021; 16(8):e0256436. PubMed ID: 34432811
[TBL] [Abstract][Full Text] [Related]
37. Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA.
Kurtz DM; Soo J; Co Ting Keh L; Alig S; Chabon JJ; Sworder BJ; Schultz A; Jin MC; Scherer F; Garofalo A; Macaulay CW; Hamilton EG; Chen B; Olsen M; Schroers-Martin JG; Craig AFM; Moding EJ; Esfahani MS; Liu CL; Dührsen U; Hüttmann A; Casasnovas RO; Westin JR; Roschewski M; Wilson WH; Gaidano G; Rossi D; Diehn M; Alizadeh AA
Nat Biotechnol; 2021 Dec; 39(12):1537-1547. PubMed ID: 34294911
[TBL] [Abstract][Full Text] [Related]
38. Liquid Biopsy: From Discovery to Clinical Application.
Alix-Panabières C; Pantel K
Cancer Discov; 2021 Apr; 11(4):858-873. PubMed ID: 33811121
[TBL] [Abstract][Full Text] [Related]
39. ctDNA monitoring using patient-specific sequencing and integration of variant reads.
Wan JCM; Heider K; Gale D; Murphy S; Fisher E; Mouliere F; Ruiz-Valdepenas A; Santonja A; Morris J; Chandrananda D; Marshall A; Gill AB; Chan PY; Barker E; Young G; Cooper WN; Hudecova I; Marass F; Mair R; Brindle KM; Stewart GD; Abraham JE; Caldas C; Rassl DM; Rintoul RC; Alifrangis C; Middleton MR; Gallagher FA; Parkinson C; Durrani A; McDermott U; Smith CG; Massie C; Corrie PG; Rosenfeld N
Sci Transl Med; 2020 Jun; 12(548):. PubMed ID: 32554709
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring.
Zviran A; Schulman RC; Shah M; Hill STK; Deochand S; Khamnei CC; Maloney D; Patel K; Liao W; Widman AJ; Wong P; Callahan MK; Ha G; Reed S; Rotem D; Frederick D; Sharova T; Miao B; Kim T; Gydush G; Rhoades J; Huang KY; Omans ND; Bolan PO; Lipsky AH; Ang C; Malbari M; Spinelli CF; Kazancioglu S; Runnels AM; Fennessey S; Stolte C; Gaiti F; Inghirami GG; Adalsteinsson V; Houck-Loomis B; Ishii J; Wolchok JD; Boland G; Robine N; Altorki NK; Landau DA
Nat Med; 2020 Jul; 26(7):1114-1124. PubMed ID: 32483360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
